Recombinant Emicizumab Biosimilar antibody

Catalog No. ABIN7795155

The Human Monoclonal anti-Emicizumab Biosimilar antibody is suitable to detect Emicizumab Biosimilar in samples from Human. It has been validated for FACS and in vivo.

Quick Overview for Recombinant Emicizumab Biosimilar antibody (ABIN7795155)

Target: Emicizumab Biosimilar

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Emicizumab Biosimilar, Human F10, F9 Monoclonal Antibody

Characteristics: The anti-human F10, F9 monoclonal antibody emicizumab biosimilar was produced in mammalian cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG4, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details

Target: Emicizumab Biosimilar

Target Type: Biosimilar